| 英文别名 |
4-((9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-yl)amino)-2-methoxybenzoic acid;4-[[9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxybenzoic acid;MLN-8237;MLN 8237;Alisertib (MLN8237);4-((9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[c]pyrimido-[4,5-e]azepin-2-yl)amino)-2-methoxybenzoic acid;Afatinib (BIBW2992) Dimaleate;MLN8237 (Alisertib);Alisertib;MLN-8237,MLN8237;MLN-823;Fluorocyclopentenylcytosine;alisertib (auroura A kinase inhibitor);4-((9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[c]pyrimido-[4,5-e]azepin-2-yl)amino)-2-meth;4-((9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[c]pyrimido-[4,5-e]azepin-2-yl)amino)-2-methoxy;MLN8237;T66ES73M18;AK105048;4-(9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-ylamino)-2-methoxybenzoic acid;4-((9-Chloro-7-(2-fluoro-6-methoxyphen;4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]b;EN300-6482023;SCHEMBL855823;Q15633917;HY-10971;EX-A024;CHEMBL483158;HMS3743E17;BCP9000956;DB05220;NSC-799329;MFCD16621243;SW219771-1;BRD-K75295174-001-05-0;BDBM50277545;4-(9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[e]pyrimido[5,4-c]azepin-2-ylamino)-2-methoxybenzoic acid;s1133;ZLHFILGSQDJULK-UHFFFAOYSA-N;HMS3673I07;Kinome_3770;MLN8237,Alisertib;Alisertib [USAN];Benzoic acid, 4-((9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido(5,4-d)(2)benzazepin-2-yl)amino)-2-methoxy-;UNII-T66ES73M18;NCGC00263271-01;CCG-264832;J-514220;Alisertib; MLN8237;Z2037281068;4-{[9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxy-benzoic acid;1028486-01-2;CHEBI:125628;NCGC00263271-10;SDCCGSBI-0646927.P001;NSC759677;AS-17005;Benzoic acid, 4-[[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxy-; 4-[[9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxybenzoic acid; MLN 8237;4-{[13-chloro-10-(2-fluoro-6-methoxyphenyl)-3,5,9-triazatricyclo[9.4.0.0,2,7]pentadeca-1(11),2(7),3,5,9,12,14-heptaen-4-yl]amino}-2-methoxybenzoic acid;Alisertib [USAN:INN];AC-25236;HMS3654E08;BRD-K75295174-001-03-5;4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl) -5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoic acid;MLN 8237 (Contain 10% DMSO);D10085;4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoic acid;SB16658;GTPL7790;NCGC00263271-02;SMR004702834;AKOS015924647;CS-0106;ALISERTIB [INN];MLN8237 (Alisertib)?;NSC-759677;MLS006011041;BCP01823;ALISERTIB [WHO-DD];NSC799329;NS00072479;Alisertib (USAN);A5B;DTXSID30145539 |